Przejdź do zawartości
Merck
Wszystkie zdjęcia(2)

Kluczowe dokumenty

MCYTOMAG-70K-PMX

Millipore

MILLIPLEX® Mouse Cytokine/Chemokine Magnetic Bead Panel - Premixed 25 Plex - Immunology Multiplex Assay

Simultaneously analyze multiple cytokine and chemokine biomarkers with Bead-Based Multiplex Assays using the Luminex technology, in mouse serum, plasma and cell culture samples.

Synonim(y):

10549 Test immunologiczny na mysie cytokiny, Test immunologiczny na mysie cytokiny Millipore, Wielokrotny test immunologiczny na mysie cytokiny

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych

Wybierz wielkość

96 WELLS
24 670,00 zł

24 670,00 zł


Dostępność produktu: Gdy zamówienie zostanie wprowadzone do naszego systemu, otrzymasz potwierdzenie zamówienia.

Więcej informacji

Wybierz wielkość

Zmień widok
96 WELLS
24 670,00 zł

About This Item

Kod UNSPSC:
12161503
eCl@ss:
32161000
NACRES:
NA.47

24 670,00 zł


Dostępność produktu: Gdy zamówienie zostanie wprowadzone do naszego systemu, otrzymasz potwierdzenie zamówienia.

Więcej informacji

Poziom jakości

reaktywność gatunkowa

mouse

producent / nazwa handlowa

Milliplex®

assay range

accuracy: 85-107%
standard curve range: 3.2-10,000 pg/mL

metody

multiplexing: suitable

kompatybilność

configured for Premixed

metoda wykrywania

fluorometric (Luminex xMAP)

Warunki transportu

wet ice

Opis ogólny

To identify specific cytokines involved in any inflammatory or immune response, it might be necessary to screen panels of cytokines, often requiring some level of automation and/or high throughput. Beads can make the process of automation and high throughput screening easier with features such as walk-away washing. Advantages even outside automation include:

  • More flexible plate and plate washer options
  • Improved performance with turbid serum/plasma samples
  • Assay results equivalent to non- beads
  • Automated washing avoids many problems associated with vacuum filtration washing


MILLIPLEX® Mouse Cytokine / Chemokine panel enables you to focus on the therapeutic potential of cytokines as well as the modulation of cytokine expression. Coupled with the Luminex® xMAP® platform in a bead format, you receive the advantage of ideal speed and sensitivity, allowing quantitative multiplex detection of dozens of analytes simultaneously, which can dramatically improve productivity.

Panel Type: Cytokines/Chemokines

Zastosowanie

  • Analytes: G-CSF, GM-CSF, IFN-γ, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17, IP-10, KC, MCP-1, MIP-1α, MIP-1β, MIP-2, RANTES, TNF-α

Inne uwagi

Sensitivity: Refer to kit protocol for sensitivities for individual cytokines.

Informacje prawne

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp
Ta strona może zawierać tekst przetłumaczony maszynowo.

Hasło ostrzegawcze

Danger

Zwroty wskazujące rodzaj zagrożenia

Klasyfikacja zagrożeń

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

Organy docelowe

Respiratory Tract

Kod klasy składowania

10 - Combustible liquids


Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Christine I Wooddell et al.
Molecular therapy : the journal of the American Society of Gene Therapy, 21(5), 973-985 (2013-02-27)
RNA interference (RNAi)-based therapeutics have the potential to treat chronic hepatitis B virus (HBV) infection in a fundamentally different manner than current therapies. Using RNAi, it is possible to knock down expression of viral RNAs including the pregenomic RNA from
Ruchi Srivastava et al.
The Journal of general virology, 96(Pt 6), 1347-1357 (2015-02-11)
West Nile virus (WNV), an important global human pathogen, targets neurons to cause lethal encephalitis, primarily in elderly and immunocompromised patients. Currently, there are no approved therapeutic agents or vaccines to treat WNV encephalitis. Recent studies have suggested that inflammation
Wei Lei et al.
PloS one, 11(8), e0160994-e0160994 (2016-08-31)
Sutherlandia frutescens is a medicinal plant that has been traditionally used in southern Africa for cancers, infections, and inflammatory conditions. We recently published experiments demonstrating that an aqueous extract of S. frutescens possessed potent immune-stimulatory activity. This work was carried
Rubia I Mancuso et al.
Immunity, inflammation and disease, 6(1), 128-142 (2017-11-10)
Streptococcus pneumoniae colonizes the nasopharynx of healthy individuals establishing a commensal relationship with the host. In some conditions, bacteria invade the lower respiratory tract and innate immune responses are crucial to avoid diseases such as pneumonia, sepsis, or meningitis. Here
Elena A Govorkova et al.
Antimicrobial agents and chemotherapy, 59(3), 1495-1504 (2014-12-24)
Compounds that target the cellular factors essential for influenza virus replication represent an innovative approach to antiviral therapy. Sp2CBMTD is a genetically engineered multivalent protein that masks sialic acid-containing cellular receptors on the respiratory epithelium, which are recognized by influenza

Questions

1–2 of 2 Questions  
  1. It seems that the sample wells are experiencing low bead counts while the standard and control wells are unaffected. This issue is limited to 1 or 2 cytokines, while the rest show normal counts. It doesn't appear to be related to the instrument, bead loss, or inadequate bead mixing. What could be the possible reason for this discrepancy?

    1 answer
    1. To reduce the occurrence of sample-related bead aggregation, the following steps can be taken:
      •Spin samples at 10,000 x g for 10 minutes immediately before preparing sample dilutions or loading samples into the plate.
      •Resuspend the plate in Wash Buffer instead of Sheath or Drive Fluid. The plate must be read within a couple of hours, and the buffer should be switched to Sheath or Drive Fluid for longer storage.
      •Dilute samples at a ratio of 1:2 or 1:4.
      •Perform more wash cycles after the primary incubation step of the assay to remove substances that cause bead aggregation.

      Helpful?

  2. Does the addition of 25 µL of Assay Buffer to the sample well count as a dilution when using a Milliplex kit that does not require a sample dilution prior to loading the plate?

    1 answer
    1. If the sample is not diluted prior to loading the plate, and the same volume of standard and sample are loaded, then there is no need to apply a sample dilution factor.

      Helpful?

Reviews

No rating value

Active Filters

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej